These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38377788)

  • 1. Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications.
    Kalyanaraman B; Cheng G; Hardy M
    Redox Biol; 2024 May; 71():103092. PubMed ID: 38377788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration.
    Mahbub NU; Islam MM; Hong ST; Chung HJ
    Front Cell Infect Microbiol; 2024; 14():1348279. PubMed ID: 38435303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocytic α-Synuclein and the Gut Microbiome: Kindling of the Gut-Brain Axis in Parkinson's Disease.
    Yang Y; Stewart T; Zhang C; Wang P; Xu Z; Jin J; Huang Y; Liu Z; Lan G; Liang X; Sheng L; Shi M; Cai Z; Zhang J
    Mov Disord; 2024 Jan; 39(1):40-52. PubMed ID: 37798868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay of human gastrointestinal microbiota metabolites: Short-chain fatty acids and their correlation with Parkinson's disease.
    Liu J; Chen Q; Su R
    Medicine (Baltimore); 2024 Apr; 103(17):e37960. PubMed ID: 38669388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota- Brain-Gut-Axis Relevance to Parkinson's Disease: Potential Therapeutic Effects of Probiotics.
    Raj K; Singh S; Chib S; Mallan S
    Curr Pharm Des; 2022; 28(37):3049-3067. PubMed ID: 36200207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
    Chen SJ; Chen CC; Liao HY; Lin YT; Wu YW; Liou JM; Wu MS; Kuo CH; Lin CH
    Neurology; 2022 Feb; 98(8):e848-e858. PubMed ID: 34996879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut brain axis: an insight into microbiota role in Parkinson's disease.
    Moustafa SA; Mohamed S; Dawood A; Azar J; Elmorsy E; Rizk NAM; Salama M
    Metab Brain Dis; 2021 Oct; 36(7):1545-1557. PubMed ID: 34370175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship Between Short-chain Fatty Acids and Parkinson's Disease: A Review from Pathology to Clinic.
    Duan WX; Wang F; Liu JY; Liu CF
    Neurosci Bull; 2024 Apr; 40(4):500-516. PubMed ID: 37755674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The link between the gut microbiota and Parkinson's Disease: A systematic mechanism review with focus on α-synuclein transport.
    Nielsen SD; Pearson NM; Seidler K
    Brain Res; 2021 Oct; 1769():147609. PubMed ID: 34371014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson's disease patients.
    Wu G; Jiang Z; Pu Y; Chen S; Wang T; Wang Y; Xu X; Wang S; Jin M; Yao Y; Liu Y; Ke S; Liu S
    BMC Neurol; 2022 Jan; 22(1):13. PubMed ID: 34996385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gut microbiome in Parkinson's disease: A culprit or a bystander?
    Keshavarzian A; Engen P; Bonvegna S; Cilia R
    Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson's disease.
    Hou Y; Li X; Liu C; Zhang M; Zhang X; Ge S; Zhao L
    Exp Gerontol; 2021 Jul; 150():111376. PubMed ID: 33905875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease.
    Sampson TR; Debelius JW; Thron T; Janssen S; Shastri GG; Ilhan ZE; Challis C; Schretter CE; Rocha S; Gradinaru V; Chesselet MF; Keshavarzian A; Shannon KM; Krajmalnik-Brown R; Wittung-Stafshede P; Knight R; Mazmanian SK
    Cell; 2016 Dec; 167(6):1469-1480.e12. PubMed ID: 27912057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease mechanisms as subtypes: Microbiome.
    Bonvegna S; Cilia R
    Handb Clin Neurol; 2023; 193():107-131. PubMed ID: 36803806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota-derived butyrate improved acute leptospirosis in hamster
    Chen X; Xie X; Sun N; Liu X; Liu J; Zhang W; Cao Y
    mBio; 2024 Oct; 15(10):e0190624. PubMed ID: 39287437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease.
    Shin Y; Han S; Kwon J; Ju S; Choi TG; Kang I; Kim SS
    Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease.
    Aho VTE; Houser MC; Pereira PAB; Chang J; Rudi K; Paulin L; Hertzberg V; Auvinen P; Tansey MG; Scheperjans F
    Mol Neurodegener; 2021 Feb; 16(1):6. PubMed ID: 33557896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinson's disease and the gastrointestinal microbiome.
    Lubomski M; Tan AH; Lim SY; Holmes AJ; Davis RL; Sue CM
    J Neurol; 2020 Sep; 267(9):2507-2523. PubMed ID: 31041582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.
    Metta V; Leta V; Mrudula KR; Prashanth LK; Goyal V; Borgohain R; Chung-Faye G; Chaudhuri KR
    J Neurol; 2022 Mar; 269(3):1154-1163. PubMed ID: 33881598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of the Gut Microbiome in Parkinson's Disease.
    Elfil M; Kamel S; Kandil M; Koo BB; Schaefer SM
    Mov Disord; 2020 Jun; 35(6):921-933. PubMed ID: 32092186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.